It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Gary W. Chmielewski, MD

Patient Feedback
  • Thoracic and Cardiac Surgery
  • Surgery
Board Certification:
  • Thoracic and Cardiac Surgery
  • Surgery
Faculty Rank: Associate Professor
Medical or Graduate Education: Loyola University Chicago Stritch School of Medicine
Residency: Wayne State University/Detroit Medical Center - Surgery
Fellowship: Wayne State University/Detroit Medical Center - Cardiothoracic Surgery
Clinical Expertise:
  • Barrett's esophagus
  • Cancer surgery, lung
  • Chest tumors
  • Esophageal cancer
  • Esophagectomy
  • Gastroesophageal reflux disease (GERD)
  • Lung cancer
  • Nissen fundoplication
  • Radiofrequency ablation
  • Thoracic surgery
  • Thoracoscopic surgery
  • Video-assisted thoracoscopic surgery (VATS)
Google Map
Google Map
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus.
    Pasricha S, Cotton C, Hathorn KE, Li N, Bulsiewicz WJ, Wolf WA, Muthusamy VR, Komanduri S, Wolfsen HC, Pruitt RE, Ertan A, Chmielewski GW, Shaheen NJ
    2015 Oct
  2. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
    Ziel E, Hermann G, Sen N, Bonomi P, Liptay MJ, Fidler MJ, Batus M, Warren WH, Chmielewski G, Sher DJ
    J Thorac Oncol
    2015 Oct
  3. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.
    Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ
    2015 Aug 28
  4. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
    Seder CW, Kubasiak JC, Pithadia R, Basu S, Fhied C, Tarhoni I, Davila E, Alnajjar H, Chmielewski GW, Warren WH, Liptay MJ, Borgia JA
    Ann. Thorac. Surg.
    2015 Aug
  5. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
    Kubasiak JC, Seder CW, Pithadia R, Basu S, Fhied C, Phillips WW, Daly S, Shersher DD, Yoder MA, Chmielewski G, Edell ES, Maldonado F, Liptay MJ, Borgia JA
    J. Thorac. Cardiovasc. Surg.
    2014 Sep 19
  6. Circulating Angiogenesis Biomarkers Are Associated With Disease Progression in Lung Adenocarcinoma.
    Daly S, Kubasiak JC, Rinewalt D, Pithadia R, Basu S, Fhied C, Lobato GC, Seder CW, Hong E, Warren WH, Chmielewski G, Liptay MJ, Bonomi P, Borgia JA
    Ann. Thorac. Surg.
    2014 Oct 6
  7. Durability and Predictors of Successful Radiofrequency Ablation for Barrett's Esophagus.
    Pasricha S, Bulsiewicz WJ, Hathorn KE, Komanduri S, Muthusamy VR, Rothstein RI, Wolfsen HC, Lightdale CJ, Overholt BF, Camara DS, Dellon ES, Lyday WD, Ertan A, Chmielewski GW, Shaheen NJ
    Clin. Gastroenterol. Hepatol.
    2014 May 7
  8. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S, Rinewalt D, Fhied C, Basu S, Mahon B, Liptay MJ, Hong E, Chmielewski G, Yoder MA, Shah PN, Edell ES, Maldonado F, Bungum AO, Borgia JA.
    J Thorac Oncol. 2013
    2013 Jan
    8(1):31-6. doi: 10.1097/JTO.0b013e31827627f8.
  9. Prior Fundoplication Does not Improve Safety or Efficacy Outcomes of Radiofrequency Ablation: Results from the U.S. RFA Registry.
    Shaheen NJ, Kim HP, Bulsiewicz WJ, Lyday WD, Triadafilopoulos G, Wolfsen HC, Komanduri S, Chmielewski GW, Ertan A, Corbett FS, Camara DS, Rothstein RI, Overholt BF.
    J Gastrointest Surg. 2013
    2013 Jan
    17(1):21-9. doi: 10.1007/s11605-012-2001-8. Epub 2012 Sep 11.
  10. Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
    Cross DM, Chmielewski G, Lewis EM, Liu L, Modesitt MS, Ripp SL, Sawaryn CM, Bowman CJ
    Regul. Toxicol. Pharmacol.
    2012 Jun
  11. Developmental toxicity study of lersivirine in mice.
    Cappon GD, Bowman CJ, Campion SN, Chmielewski G, Hurtt ME, Finch GL, Lewis EM
    Birth Defects Res. B Dev. Reprod. Toxicol.
    2012 Jun
  12. Tissue distribution of anidulafungin in neonatal rats.
    Ripp SL, Aram JA, Bowman CJ, Chmielewski G, Conte U, Cross DM, Gao H, Lewis EM, Lin J, Liu P, Schlamm HT
    Birth Defects Res. B Dev. Reprod. Toxicol.
    2012 Feb
  13. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients.
    Rinewalt D, Shersher DD, Daly S, Fhied C, Basu S, Mahon B, Hong E, Chmielewski G, Liptay MJ, Borgia JA.
    J Thorac Cardiovasc Surg. 2012
    2012 Dec
    144(6):1344-50; discussion 1350-1. doi: 10.1016/j.jtcvs.2012.08.033. Epub 2012 Sep 13.
  14. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F, Nancarrow-Tull J, Shah C, Chmielewski G, Fakhouri M, Sitarek SA, Feczko CT, Brzozowski C, Felten DL.
    Cancer. 2011
    2011 Oct 15
    117(20):4764-71. doi: 10.1002/cncr.26094. Epub 2011 Mar 31.
  15. Benign post-esophagectomy gastrocardiac fistula.
    Pentiak P, Seder CW, Chmielewski GW, Welsh RJ.
    Interact Cardiovasc Thorac Surg. 2011
    2011 Oct
    13(4):447-9. doi: 10.1510/icvts.2011.276790. Epub 2011 Jul 25.
  16. Rapid disease progression with delay in treatment of non-small-cell lung cancer.
    Mohammed N, Kestin LL, Grills IS, Battu M, Fitch DL, Wong CY, Margolis JH, Chmielewski GW, Welsh RJ.
    Int J Radiat Oncol Biol Phys. 2011
    2011 Feb 1
    79(2):466-72. doi: 10.1016/j.ijrobp.2009.11.029. Epub 2010 May 13.
  17. Feeding jejunostomy tubes placed during esophagectomy: are they necessary?
    Fenton JR, Bergeron EJ, Coello M, Welsh RJ, Chmielewski GW.
    Ann Thorac Surg. 2011
    2011 Aug
    92(2):504-11; discussion 511-2. doi: 10.1016/j.athoracsur.2011.03.101. Epub 2011 Jun 24.
  18. Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges.
    Bowman CJ, Chmielewski G, Lewis E, Ripp S, Sawaryn CM, Cross DM
    Birth Defects Res. B Dev. Reprod. Toxicol.
    2011 Aug
  19. Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors.
    Mohammed N, Grills IS, Wong CY, Galerani AP, Chao K, Welsh R, Chmielewski G, Yan D, Kestin LL.
    Radiother Oncol. 2011
    2011 Apr
    99(1):18-22. doi: 10.1016/j.radonc.2011.03.003. Epub 2011 Mar 30.
  20. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection.
    Agarwal M, Brahmanday G, Chmielewski GW, Welsh RJ, Ravikrishnan KP.
    Lung Cancer. 2010
    2010 Jun
    68(3):398-402. doi: 10.1016/j.lungcan.2009.08.008. Epub 2009 Sep 16.
  21. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, Wloch J, Ye H, Kestin LL.
    J Clin Oncol. 2010
    2010 Feb 20
    28(6):928-35. doi: 10.1200/JCO.2009.25.0928. Epub 2010 Jan 11.
  22. Nonoperative management of postintubation tracheal injuries.
    Fong PA, Seder CW, Chmielewski GW, Welsh RJ.
    Ann Thorac Surg. 2010
    2010 Apr
    89(4):1265-6. doi: 10.1016/j.athoracsur.2009.07.093.
  23. The safe transition from open to thoracoscopic lobectomy: a 5-year experience.
    Seder CW, Hanna K, Lucia V, Boura J, Kim SW, Welsh RJ, Chmielewski GW.
    Ann Thorac Surg. 2009
    2009 Jul
    88(1):216-25; discussion 225-6. doi: 10.1016/j.athoracsur.2009.04.017.
  24. Empyema--a complication of vacuum-assisted closure of infected thoracotomy wounds in two consecutive cases.
    Patel NV, Shah RD, Welsh RJ, Chmielewski GW.
    Am Surg. 2009
    2009 Apr
    75(4):349-50. No abstract available.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.